Zusammenfassung
Erklärungsmodelle zur Ursache und Entstehung von Fatigue-Syndromen gehen von multifaktoriellen ätiologischen und pathogenetischen Vorgängen aus. Auslösende und aufrechterhaltende Prozesse sowie Schutz- und Risikofaktoren sind daran beteiligt, aber auch Regelungsprozesse von physiologischen Müdigkeits- und Erschöpfungszuständen. Die Tumorerkrankung und die antineoplastischen Therapien spielen bei der Entstehung zentrale Rollen, sowohl als auslösende als auch als aufrechterhaltende Faktoren. Sie können voneinander unabhängig oder gemeinsam wirken und über eine Vielzahl pathophysiologischer Prozesse zum Störungsbild führen. Weiterhin bestimmen erbliche und psychosoziale Faktoren die individuelle Vulnerabilität für Fatigue. Trotz intensiver Forschungsbemühungen und vieler neuer Erkenntnisse ist es bisher nicht möglich, die genauen Anteile der verschiedenen Einflussfaktoren zu bestimmen. Es deutet sich aber an, dass nicht einzelne von ihnen den Entstehungsprozess bestimmen, sondern erst ihre Wechselwirkungen zu den Veränderungen in den Regulationssystemen des Organismus führen, die als Fatiguesymptomatik wahrgenommen wird. Den bisherigen Erklärungsmodellen ist gemeinsam, dass sie noch nicht umfassend empirisch fundiert sind. Dennoch haben sie eine Bedeutung für die Grundlagen und Therapieforschung und einen heuristischen Wert für das Verständnis der Fatigue sowie die diagnostische und therapeutische Praxis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Abrahams, H. J., Gielissen, M. F., Schmits, I. C., Verhagen, C. A., Rovers, M. M., & Knoop, H. (2016). Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: A meta-analysis involving 12 327 breast cancer survivors. Annals of Oncology, 27(6), 965–974.
Adam, E. K., Quinn, M. E., Tavernier, R., McQuillan, M. T., Dahlke, K. A., & Gilbert, K. E. (2017). Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis. Psychoneuroendocrinology, 83, 25–41. https://doi.org/10.1016/j.psyneuen.2017.05.018
Al Maqbali, M., Al Sinani, M., Al Naamani, Z., Al Badi, K., & Tanash, M. (2021). Prevalence of fatigue in patients with cancer: A systematic review and meta-analysis. Journal of Pain and Symptom Management, 61(1), 167–189.e114. https://doi.org/10.1016/j.jpainsymman.2020.07.037
Alcantara-Silva, T. R., Freitas-Junior, R., Freitas, N. M., & Machado, G. D. (2013). Fatigue related to radiotherapy for breast and/or gynaecological cancer: A systematic review. Journal of Clinical Nursing, 22(19–20), 2679–2686.
Alcântara-Silva, T. R., de Freitas-Junior, R., Freitas, N. M. A., de Paula Junior, W., da Silva, D. J., Machado, G. D. P., Ribeiro, M. K. A., Carneiro, J. P., & Soares, L. R. (2018). Music therapy reduces radiotherapy-induced fatigue in patients with breast or gynecological cancer: A randomized trial. Integrative Cancer Therapies, 17(3), 628–635. https://doi.org/10.1177/1534735418757349
Allexandre, D., Seyidova-Khoshknabi, D., Davis, M. P., Ranganathan, V. K., Siemionow, V., Walsh, D., & Yue, G. H. (2020). EEG correlates of central origin of cancer-related fatigue. Neural Plasticity, 2020, 8812984. https://doi.org/10.1155/2020/8812984
Ancoli-Israel, S., Liu, L., Rissling, M., Natarajan, L., Neikrug, A. B., Palmer, B. W., Mills, P. J., Parker, B. A., Sadler, G. R., & Maglione, J. (2014). Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: A 1-year longitudinal study. Supportive Care in Cancer, 22(9), 2535–2545. https://doi.org/10.1007/s00520-014-2204-5
Andrykowski, M. A., Donovan, K. A., Laronga, C., & Jacobsen, P. B. (2010). Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer, 116(24), 5740–5748.
Arya, N., Vaish, A., Zhao, K., & Rao, H. (2021). Neural mechanisms underlying breast cancer related fatigue: A systematic review of neuroimaging studies. Frontiers in Neuroscience, 15, 735945. https://doi.org/10.3389/fnins.2021.735945
Behranvand, N., Nasri, F., Emmameh, Z., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2021). Chemotherapy: A double-edged sword in cancer treatment. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-021-03013-3
Bødtcher, H., Bidstrup, P. E., Andersen, I., Christensen, J., Mertz, B. G., Johansen, C., & Dalton, S. O. (2015). Fatigue trajectories during the first 8 months after breast cancer diagnosis. Quality of Life Research, 24(11), 2671–2679. https://doi.org/10.1007/s11136-015-1000-0
Bohlen, J., McLaughlin, S. L., Hazard-Jenkins, H., Infante, A. M., Montgomery, C., Davis, M., & Pistilli, E. E. (2018). Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: Preclinical evaluation of interleukin-15 targeting fatigue. J Cachexia Sarcopenia Muscle, 9(4), 701–714. https://doi.org/10.1002/jcsm.12294
Bower, J. E. (2014). Cancer-related fatigue – Mechanisms, risk factors, and treatments. Nature Reviews: Clinical Oncology, 11(10), 597–609.
Bower, J. E. (2019). The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms. Cancer, 125(3), 353–364. https://doi.org/10.1002/cncr.31790
Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64(4), 604–611.
Bower, J. E., Ganz, P. A., & Aziz, N. (2005a). Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosomatic Medicine, 67(2), 277–280.
Bower, J. E., Ganz, P. A., Dickerson, S. S., Petersen, L., Aziz, N., & Fahey, J. L. (2005b). Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology, 30(1), 92–100. https://doi.org/10.1016/j.psyneuen.2004.06.003
Bower, J. E., Ganz, P. A., Tao, M. L., Hu, W., Belin, T. R., Sepah, S., Cole, S., & Aziz, N. (2009). Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clinical Cancer Research, 15(17), 5534–5540.
Bower, J. E., Ganz, P. A., Irwin, M. R., Arevalo, J. M., & Cole, S. W. (2011). Fatigue and gene expression in human leukocytes: Increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain, Behavior, and Immunity, 25(1), 147–150. https://doi.org/10.1016/j.bbi.2010.09.010
Bower, J. E., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., & Greendale, G. (2012). Yoga for persistent fatigue in breast cancer survivors: A randomized controlled trial. Cancer, 118(15), 3766–3775.
Bower, J. E., Ganz, P. A., Irwin, M. R., Castellon, S., Arevalo, J., & Cole, S. W. (2013). Cytokine genetic variations and fatigue among patients with breast cancer. Journal of Clinical Oncology, 31(13), 1656–1661.
Bower, J. E., Wiley, J., Petersen, L., Irwin, M. R., Cole, S. W., & Ganz, P. A. (2018). Fatigue after breast cancer treatment: Biobehavioral predictors of fatigue trajectories. Health Psychology, 37(11), 1025–1034. https://doi.org/10.1037/hea0000652
Bower, J. E., Ganz, P. A., Irwin, M. R., Cole, S. W., Garet, D., Petersen, L., Asher, A., Hurvitz, S. A., & Crespi, C. M. (2021). Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer. Cancer, 127(8), 1334–1344. https://doi.org/10.1002/cncr.33327
Brook, R. D., & Julius, S. (2000). Autonomic imbalance, hypertension, and cardiovascular risk. American Journal of Hypertension, 13(6 Pt 2), 112S–122S. https://doi.org/10.1016/s0895-7061(00)00228-4
Brown, A. L., Sok, P., Taylor, O., Woodhouse, J. P., Bernhardt, M. B., Raghubar, K. P., Kahalley, L. S., Lupo, P. J., Hockenberry, M. J., & Scheurer, M. E. (2021). Cerebrospinal fluid metabolomic profiles associated with fatigue during treatment for pediatric acute lymphoblastic leukemia. Journal of Pain and Symptom Management, 61(3), 464–473. https://doi.org/10.1016/j.jpainsymman.2020.08.030
Bruera, E., Valero, V., Driver, L., Shen, L., Willey, J., Zhang, T., & Palmer, J. L. (2006). Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. Journal of Clinical Oncology, 24(13), 2073–2078.
Cai, B., Allexandre, D., Rajagopalan, V., Jiang, Z., Siemionow, V., Ranganathan, V. K., Davis, M. P., Walsh, D., Dai, K., & Yue, G. H. (2014). Evidence of significant central fatigue in patients with cancer-related fatigue during repetitive elbow flexions till perceived exhaustion. PloS One, 9(12), e115370. https://doi.org/10.1371/journal.pone.0115370
Cameron, B., Webber, K., Li, H., Bennett, B. K., Boyle, F., de Souza, P., Wilcken, N., Lynch, J., Friedlander, M., Goldstein, D., & Lloyd, A. R. (2021). Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study. Brain Behav Immun Health, 10, 100189. https://doi.org/10.1016/j.bbih.2020.100189
Ceunen, E., Vlaeyen, J. W. S., & Van Diest, I. (2016). On the origin of interoception [Review]. Frontiers in Psychology, 7. https://doi.org/10.3389/fpsyg.2016.00743
Chartogne, M., Leclercq, A., Beaune, B., Boyas, S., Forestier, C., Martin, T., Thomas-Ollivier, V., Landry, S., Bourgeois, H., Cojocarasu, O., Pialoux, V., Zanna, O., Messonnier, L. A., Rahmani, A., & Morel, B. (2021). Building a biopsychosocial model of cancer-related fatigue: The BIOCARE FActory cohort study protocol. BMC Cancer, 21(1), 1140. https://doi.org/10.1186/s12885-021-08831-3
Chen, W. G., Schloesser, D., Arensdorf, A. M., Simmons, J. M., Cui, C., Valentino, R., Gnadt, J. W., Nielsen, L., Hillaire-Clarke, C. S., Spruance, V., Horowitz, T. S., Vallejo, Y. F., & Langevin, H. M. (2021). The emerging science of interoception: Sensing, integrating, interpreting, and regulating signals within the self. Trends in Neurosciences, 44(1), 3–16. https://doi.org/10.1016/j.tins.2020.10.007
Chrousos, G. P., & Gold, P. W. (1992). The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. JAMA, 267(9), 1244–1252. https://doi.org/10.1001/jama.1992.03480090092034
Cohen, R. A., Gullett, J. M., Woods, A. J., Porges, E. C., Starkweather, A., Jackson-Cook, C. K., Lynch-Kelly, D. L., & Lyon, D. E. (2019). Cytokine-associated fatigue prior to, during, and post-chemotherapy for breast cancer. Journal of Neuroimmunology, 334, 577001. https://doi.org/10.1016/j.jneuroim.2019.577001
Coumbe, B. G. T., & Groarke, J. D. (2018). Cardiovascular autonomic dysfunction in patients with cancer. Current Cardiology Reports, 20(8), 69. https://doi.org/10.1007/s11886-018-1010-y
Crosswell, A. D., Lockwood, K. G., Ganz, P. A., & Bower, J. E. (2014). Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinology, 45, 58–66. https://doi.org/10.1016/j.psyneuen.2014.03.011
Cuneo, M. G., Schrepf, A., Slavich, G. M., Thaker, P. H., Goodheart, M., Bender, D., Cole, S. W., Sood, A. K., & Lutgendorf, S. K. (2017). Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer. Psychoneuroendocrinology, 84, 139–142. https://doi.org/10.1016/j.psyneuen.2017.06.019
Dantzer, R., & Kelley, K. W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21(2), 153–160. https://doi.org/10.1016/j.bbi.2006.09.006
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews: Neuroscience, 9(1), 46–56. https://doi.org/10.1038/nrn2297
Dantzer, R., Heijnen, C. J., Kavelaars, A., Laye, S., & Capuron, L. (2014). The neuroimmune basis of fatigue. Trends in Neurosciences, 37(1), 39–46.
Deary, V., Hagenaars, S. P., Harris, S. E., Hill, W. D., Davies, G., Liewald, D. C. M., McIntosh, A. M., Gale, C. R., Deary, I. J., & International Consortium for Blood Pressure, G., Aging, C. C., Longevity, G., & Group, C. C. I. (2018). Genetic contributions to self-reported tiredness. Molecular Psychiatry, 23(3), 609–620. https://doi.org/10.1038/mp.2017.5
Devlin, B. A., Smith, C. J., & Bilbo, S. D. (2021). Sickness and the social brain: How the immune system regulates behavior across species. Brain, Behavior and Evolution. https://doi.org/10.1159/000521476
Di Meglio, A., Havas, J., Soldato, D., Presti, D., Martin, E., Pistilli, B., Menvielle, G., Dumas, A., Charles, C., Everhard, S., Martin, A.-L., Coutant, C., Tarpin, C., Vanlemmens, L., Levy, C., Rigal, O., Delaloge, S., Lin, N. U., Ganz, P. A., et al. (2022). Development and validation of a predictive model of severe fatigue after breast cancer diagnosis: Toward a personalized framework in survivorship care. Journal of Clinical Oncology, 40(10), 1111–1123. https://doi.org/10.1200/JCO.21.01252
Draper, A., Koch, R. M., van der Meer, J. W., Aj Apps, M., Pickkers, P., Husain, M., & van der Schaaf, M. E. (2018). Effort but not reward sensitivity is altered by acute sickness induced by experimental endotoxemia in humans. Neuropsychopharmacology, 43(5), 1107–1118. https://doi.org/10.1038/npp.2017.231
Egger, J. W. (2008). Das biopsychosoziale Krankheitsmodell – Gründzüge eines wissenschaftlich begründenten ganzheitlichen Verständnisses von Krankheit., 16. Jahrgang, Nummer 12.
Eshragh, J., Dhruva, A., Paul, S. M., Cooper, B. A., Mastick, J., Hamolsky, D., Levine, J. D., Miaskowski, C., & Kober, K. M. (2017). Associations between neurotransmitter genes and fatigue and energy levels in women after breast cancer surgery. Journal of Pain and Symptom Management, 53(1), 67–84.e67. https://doi.org/10.1016/j.jpainsymman.2016.08.004
Fagundes, C. P., Murray, D. M., Hwang, B. S., Gouin, J. P., Thayer, J. F., Sollers, J. J., 3rd, Shapiro, C. L., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2011). Sympathetic and parasympathetic activity in cancer-related fatigue: More evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology, 36(8), 1137–1147. https://doi.org/10.1016/j.psyneuen.2011.02.005
Fava, G. A., McEwen, B. S., Guidi, J., Gostoli, S., Offidani, E., & Sonino, N. (2019). Clinical characterization of allostatic overload. Psychoneuroendocrinology, 108, 94–101. https://doi.org/10.1016/j.psyneuen.2019.05.028
Feng, L. R., Fernández-Martínez, J. L., Zaal, K. J. M., deAndrés-Galiana, E. J., Wolff, B. S., & Saligan, L. N. (2018). mGluR5 mediates post-radiotherapy fatigue development in cancer patients. Translational Psychiatry, 8(1), 110. https://doi.org/10.1038/s41398-018-0161-3
Feng, L. R., Fuss, T., Dickinson, K., Ross, A., & Saligan, L. N. (2019). Co-occurring symptoms contribute to persistent fatigue in prostate cancer. Oncology, 96(4), 183–191. https://doi.org/10.1159/000494620
Feng, L. R., Juneau, P., Regan, J. M., Liwang, J., Alshawi, S., Wang, A., & Saligan, L. N. (2020). Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue. Translational Psychiatry, 10(1), 302. https://doi.org/10.1038/s41398-020-00990-4
Fernandez-de-Las-Penas, C., Cantarero-Villanueva, I., Fernandez-Lao, C., Ambite-Quesada, S., Diaz-Rodriguez, L., Rivas-Martinez, I., del Moral-Avila, R., & Arroyo-Morales, M. (2012a). Influence of catechol-o-methyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivors. Breast, 21(2), 199–203.
Fernandez-de-Las-Penas, C., Fernandez-Lao, C., Cantarero-Villanueva, I., Ambite-Quesada, S., Rivas-Martinez, I., del Moral-Avila, R., & Arroyo-Morales, M. (2012b). Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Research and Treatment, 133(2), 405–412.
Feyer, P., Steingräber, M., & Titlbach, O. (2004). Besonderheiten der Fatigue bei radioonkologischen Patienten. Journal Onkologie, 6, 16–19.
Fosså, A., Smeland, K. H., Fluge, Ø., Tronstad, K. J., Loge, J. H., Midttun, Ø., Ueland, P. M., & Kiserud, C. E. (2020). Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue. PloS One, 15(1), e0227384. https://doi.org/10.1371/journal.pone.0227384
Ganz, P. A., & Bower, J. E. (2007). Cancer related fatigue: A focus on breast cancer and Hodgkin’s disease survivors. Acta Oncologica, 46(4), 474–479.
Ganzel, B. L., Morris, P. A., & Wethington, E. (2010). Allostasis and the human brain: Integrating models of stress from the social and life sciences. Psychological Review, 117(1), 134–174. https://doi.org/10.1037/a0017773
Hajdarevic, R., Lande, A., Mehlsen, J., Rydland, A., Sosa, D. D., Strand, E. B., Mella, O., Pociot, F., Fluge, Ø., Lie, B. A., & Viken, M. K. (2022). Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci. Brain, Behavior, and Immunity, 102, 362–369. https://doi.org/10.1016/j.bbi.2022.03.010
Geraghty, K., Jason, L., Sunnquist, M., Tuller, D., Blease, C., & Adeniji, C. (2019). The “cognitive behavioural model” of chronic fatigue syndrome: Critique of a flawed model. Health Psychology Open, 6(1). https://doi.org/10.1177/2055102919838907
Goedendorp, M. M., Gielissen, M. F., Verhagen, C. A., Peters, M. E., & Bleijenberg, G. (2008). Severe fatigue and related factors in cancer patients before the initiation of treatment. British Journal of Cancer, 99(9), 1408–1414. https://doi.org/10.1038/sj.bjc.6604739
Goertzel, B. N., Pennachin, C., de Souza, C. L., Gurbaxani, B., Maloney, E. M., & Jones, J. F. (2006). Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics, 7(3), 475–483.
Goto, T., Von Ah, D., Li, X., Xiang, L., Kwiat, C., Nguyen, C., Hsiao, C. P., & Saligan, L. N. (2023). Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors. Journal of Cancer Survivorship, https://doi.org/10.1007/s11764-023-01426-w
Greenhouse-Tucknott, A., Butterworth, J. B., Wrightson, J. G., Smeeton, N. J., Critchley, H. D., Dekerle, J., & Harrison, N. A. (2021). Toward the unity of pathological and exertional fatigue: A predictive processing model. Cognitive, Affective & Behavioral Neuroscience. https://doi.org/10.3758/s13415-021-00958-x
Grossberg, A. J., Vichaya, E. G., Gross, P. S., Ford, B. G., Scott, K. A., Estrada, D., Vermeer, D. W., Vermeer, P., & Dantzer, R. (2020). Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigue. Brain, Behavior, and Immunity, 88, 230–241. https://doi.org/10.1016/j.bbi.2020.05.043
Guidi, J., Lucente, M., Sonino, N., & Fava, G. A. (2021). Allostatic load and its impact on health: A systematic review. Psychotherapy and Psychosomatics, 90(1), 11–27. https://doi.org/10.1159/000510696
Hajj, A., Chamoun, R., Salameh, P., Khoury, R., Hachem, R., Sacre, H., Chahine, G., Kattan, J., & Rabbaa Khabbaz, L. (2022). Fatigue in breast cancer patients on chemotherapy: A cross-sectional study exploring clinical, biological, and genetic factors. BMC Cancer, 22(1), 16. https://doi.org/10.1186/s12885-021-09072-0
Hall, K. T., Battinelli, E., Chasman, D. I., Ridker, P. M., Psaty, B. M., Rotter, J. I., Kaptchuk, T. J., Tracy, R. P., Wassel, C. L., & Mukamal, K. J. (2019). Catechol-O-methyltransferase and cardiovascular disease: MESA. Journal of the American Heart Association, 8(24), e014986. https://doi.org/10.1161/JAHA.119.014986
Hampson, J. P., Zick, S. M., Khabir, T., Wright, B. D., & Harris, R. E. (2015). Altered resting brain connectivity in persistent cancer related fatigue. Neuroimage Clin, 8, 305–313.
Harrison, P. J., & Tunbridge, E. M. (2008). Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 33(13), 3037–3045. https://doi.org/10.1038/sj.npp.1301543
Harvey, S. B., & Wessely, S. (2009). Chronic fatigue syndrome: Identifying zebras amongst the horses. BMC Medicine, 7, 58.
Hernandez, C., Huebener, P., & Schwabe, R. F. (2016). Damage-associated molecular patterns in cancer: A double-edged sword. Oncogene, 35(46), 5931–5941. https://doi.org/10.1038/onc.2016.104
Hoenemeyer, T. W., Baidwan, N. K., Hall, K., Kaptchuk, T. J., Fontaine, K. R., & Mehta, T. S. (2021). An exploratory analysis of the association between catechol-o-methyltransferase and response to a randomized open-label placebo treatment for cancer-related fatigue. Front Psychiatry, 12, 684556. https://doi.org/10.3389/fpsyt.2021.684556
Iftikhar, A., Islam, M., Shepherd, S., Jones, S., & Ellis, I. (2021). Cancer and stress: Does it make a difference to the patient when these two challenges collide? Cancers, 13(2). https://doi.org/10.3390/cancers13020163
Inoue, H., Tsutsumi, H., Tanaka, K., Iwama, E., Shiraishi, Y., Hirayama, A., Nakanishi, T., Ando, H., Nakajima, M., Shinozaki, S., Ogata, H., Uryu, K., Okamura, K., Kimura, S., Ogawa, T., Ota, K., Yoneshima, Y., Hamada, N., Nakanishi, Y., & Okamoto, I. (2021). Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer. Translational Lung Cancer Research, 10(6), 2475–2486.
Jabir, R. S., Ho, G. F., Annuar, M., & Stanslas, J. (2018). association of allelic interaction of single nucleotide polymorphisms of influx and efflux transporters genes with nonhematologic adverse events of docetaxel in breast cancer patients. Clinical Breast Cancer, 18(5), e1173–e1179. https://doi.org/10.1016/j.clbc.2018.04.018
Jason, L., Benton, M., Torres-Harding, S., & Muldowney, K. (2009). The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS. Patient Education and Counseling, 77(2), 237–241. https://doi.org/10.1016/j.pec.2009.02.015
Junghaenel, D. U., Cohen, J., Schneider, S., Neerukonda, A. R., & Broderick, J. E. (2015). Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy. Supportive Care in Cancer, 23(9), 2579–2587. https://doi.org/10.1007/s00520-015-2616-x
Karshikoff, B., Sundelin, T., & Lasselin, J. (2017). Role of inflammation in human fatigue: Relevance of multidimensional assessments and potential neuronal mechanisms. Frontiers in Immunology, 8, 21. https://doi.org/10.3389/fimmu.2017.00021
Kelley, K. W., & Kent, S. (2020). The legacy of sickness behaviors. Front Psychiatry, 11, 607269. https://doi.org/10.3389/fpsyt.2020.607269
Kim, S., Miller, B. J., Stefanek, M. E., & Miller, A. H. (2015). Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue. Cancer, 121(13), 2129–2136.
Kisiel-Sajewicz, K., Davis, M. P., Siemionow, V., Seyidova-Khoshknabi, D., Wyant, A., Walsh, D., Hou, J., & Yue, G. H. (2012). Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in patients with cancer-related fatigue. Journal of Pain and Symptom Management, 44(3), 351–361. https://doi.org/10.1016/j.jpainsymman.2011.08.007
Kisiel-Sajewicz, K., Siemionow, V., Seyidova-Khoshknabi, D., Davis, M. P., Wyant, A., Ranganathan, V. K., Walsh, D., Yan, J. H., Hou, J., & Yue, G. H. (2013). Myoelectrical manifestation of fatigue less prominent in patients with cancer related fatigue. PloS One, 8(12), e83636. https://doi.org/10.1371/journal.pone.0083636
Kleckner, I. R., Zhang, J., Touroutoglou, A., Chanes, L., Xia, C., Simmons, W. K., Quigley, K. S., Dickerson, B. C., & Feldman Barrett, L. (2017). Evidence for a large-scale brain system supporting allostasis and interoception in humans. Nature Human Behaviour, 1(5), 0069. https://doi.org/10.1038/s41562-017-0069
Knoop, H., Prins, J. B., Moss-Morris, R., & Bleijenberg, G. (2010). The central role of cognitive processes in the perpetuation of chronic fatigue syndrome. Journal of Psychosomatic Research, 68(5), 489–494. https://doi.org/10.1016/j.jpsychores.2010.01.022
Kober, K. M., Smoot, B., Paul, S. M., Cooper, B. A., Levine, J. D., & Miaskowski, C. (2016). Polymorphisms in cytokine genes are associated with higher levels of fatigue and lower levels of energy in women after breast cancer surgery. Journal of Pain and Symptom Management, 52(5), 695–708.e694. https://doi.org/10.1016/j.jpainsymman.2016.04.014
Kreissl, S., Mueller, H., Goergen, H., Mayer, A., Brillant, C., Behringer, K., Halbsguth, T. V., Hitz, F., Soekler, M., Shonukan, O., Rueffer, J. U., Flechtner, H. H., Fuchs, M., Diehl, V., Engert, A., & Borchmann, P. (2016). Cancer-related fatigue in patients with and survivors of Hodgkin’s lymphoma: A longitudinal study of the German Hodgkin Study Group. Lancet Oncology, 17(10), 1453–1462.
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013). Immunogenic cell death in cancer therapy. Annual Review of Immunology, 31, 51–72. https://doi.org/10.1146/annurev-immunol-032712-100008
Kühl, T., Behrens, S., Jung, A. Y., Obi, N., Thöne, K., Schmidt, M. E., Becher, H., & Chang-Claude, J. (2018). Validation of inflammatory genetic variants associated with long-term cancer related fatigue in a large breast cancer cohort. Brain, Behavior, and Immunity, 73, 252–260. https://doi.org/10.1016/j.bbi.2018.05.009
Kumari, R., & Jat, P. (2021). Mechanisms of cellular senescence: Cell cycle arrest and senescence associated secretory phenotype. Frontiers in Cell and Developmental Biology, 9, 645593. https://doi.org/10.3389/fcell.2021.645593
Kuppuswamy, A. (2017). The fatigue conundrum. Brain, 140(8), 2240–2245. https://doi.org/10.1093/brain/awx153
Lacourt, T. E., Vichaya, E. G., Chiu, G. S., Dantzer, R., & Heijnen, C. J. (2018a). The high costs of low-grade inflammation: Persistent fatigue as a consequence of reduced cellular-energy availability and non-adaptive energy expenditure. Frontiers in Behavioral Neuroscience, 12, 78. https://doi.org/10.3389/fnbeh.2018.00078
Lacourt, T. E., Vichaya, E. G., Escalante, C., Manzullo, E. F., Gunn, B., Hess, K. R., Heijnen, C. J., & Dantzer, R. (2018b). An effort expenditure perspective on cancer-related fatigue. Psychoneuroendocrinology, 96, 109–117. https://doi.org/10.1016/j.psyneuen.2018.06.009
Lacourt, T. E., Kavelaars, A., Tripathy, D., & Heijnen, C. J. (2022). Associations between fatigue and cellular metabolism in breast cancer patients: A longitudinal study. Psychoneuroendocrinology, 144, 105866. https://doi.org/10.1016/j.psyneuen.2022.105866
Lasselin, J., Treadway, M. T., Lacourt, T. E., Soop, A., Olsson, M. J., Karshikoff, B., Paues-Göranson, S., Axelsson, J., Dantzer, R., & Lekander, M. (2017). Lipopolysaccharide alters motivated behavior in a monetary reward task: A randomized trial. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 42(4), 801–810. https://doi.org/10.1038/npp.2016.191
Lavigne, C., Lau, H., Francis, G., Culos-Reed, S. N., Millet, G. Y., & Twomey, R. (2020). Neuromuscular function and fatigability in people diagnosed with head and neck cancer before versus after treatment. European Journal of Applied Physiology, 120(6), 1289–1304. https://doi.org/10.1007/s00421-020-04362-0
Lee, S., Deasy, J. O., Oh, J. H., Di Meglio, A., Dumas, A., Menvielle, G., Charles, C., Boyault, S., Rousseau, M., Besse, C., Thomas, E., Boland, A., Cottu, P., Tredan, O., Levy, C., Martin, A.-L., Everhard, S., Ganz, P. A., Partridge, A. H., et al. (2020). Prediction of breast cancer treatment-induced fatigue by machine learning using genome-wide association data. JNCI cancer spectrum, 4(5), pkaa039. https://doi.org/10.1093/jncics/pkaa039
Maes, M., & Twisk, F. N. (2010). Chronic fatigue syndrome: Harvey and Wessely’s (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Medicine, 8, 35.
Maloney, E. M., Boneva, R., Nater, U. M., & Reeves, W. C. (2009). Chronic fatigue syndrome and high allostatic load: Results from a population-based case-control study in Georgia. Psychosomatic Medicine, 71(5), 549–556. https://doi.org/10.1097/PSY.0b013e3181a4fea8
Malyuchenko, N. V., Schegolkova, J. V., Kulikova, M. A., Timofeeva, M. A., Shlepzova, V. A., Sysoeva, O. V., Ivanitsky, A. M., & Tonevitsky, A. G. (2010). Effects of genetic variations in the dopaminergic system on fatigue in humans: Gender aspects. Bulletin of Experimental Biology and Medicine, 149(2), 226–232. https://doi.org/10.1007/s10517-010-0913-4
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454(7203), 436–444. https://doi.org/10.1038/nature07205
Mantovani, G., Maccio, A., Madeddu, C., Serpe, R., Antoni, G., Massa, E., Dessi, M., & Panzone, F. (2010). Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. Journal of Molecular Medicine (Berlin, Germany), 88(1), 85–92.
Marcora, S. M., Staiano, W., & Manning, V. (2009). Mental fatigue impairs physical performance in humans. Journal of Applied Physiology, 106(3), 857–864. https://doi.org/10.1152/japplphysiol.91324.2008
Matsumura, S., Wang, B., Kawashima, N., Braunstein, S., Badura, M., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., & Demaria, S. (2008). Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. Journal of Immunology (Baltimore, Md.: 1950), 181(5), 3099–3107. https://doi.org/10.4049/jimmunol.181.5.3099
Matura, L. A., Malone, S., Jaime-Lara, R., & Riegel, B. (2018). A systematic review of biological mechanisms of fatigue in chronic illness. Biological Research for Nursing, 20(4), 410–421. https://doi.org/10.1177/1099800418764326
Maurer, T., Jaskulski, S., Behrens, S., Jung, A. Y., Obi, N., Johnson, T., Becher, H., & Chang-Claude, J. (2021). Tired of feeling tired – The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors. Breast (Edinburgh, Scotland), 56, 103–109. https://doi.org/10.1016/j.breast.2021.02.008
McEwen, B. S. (2004). Protection and damage from acute and chronic stress: Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Annals of the New York Academy of Sciences, 1032(1), 1–7. https://doi.org/10.1196/annals.1314.001
McEwen, B. S. (2019). What is the confusion with cortisol? Chronic Stress, 3. https://doi.org/10.1177/2470547019833647
McEwen, B. S., & Wingfield, J. C. (2003). The concept of allostasis in biology and biomedicine. Hormones and Behavior, 43(1), 2–15. https://doi.org/10.1016/S0018-506X(02)00024-7
Meraner, V., Gamper, E. M., Grahmann, A., Giesinger, J. M., Wiesbauer, P., Sztankay, M., Zeimet, A. G., Sperner-Unterweger, B., & Holzner, B. (2012). Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer, 12, 77.
Michiels, V., & Cluydts, R. (2001). Neuropsychological functioning in chronic fatigue syndrome: A review: Neuropsychological functioning in CFS. Acta Psychiatrica Scandinavica, 103(2), 84–93. https://doi.org/10.1034/j.1600-0447.2001.00017.x
Miller, G. E., Chen, E., & Parker, K. J. (2011). Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms. Psychological Bulletin, 137(6), 959–997. https://doi.org/10.1037/a0024768
Minton, O., Alexander, S., & Stone, P. C. (2012). Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment. Breast Cancer Research and Treatment, 136(2), 513–520.
Montoya, J. G., Holmes, T. H., Anderson, J. N., Maecker, H. T., Rosenberg-Hasson, Y., Valencia, I. J., Chu, L., Younger, J. W., Tato, C. M., & Davis, M. M. (2017). Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proceedings of the National Academy of Sciences of the United States of America, 114(34), E7150–E7158. https://doi.org/10.1073/pnas.1710519114
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017). Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews: Immunology, 17(9), 559–572. https://doi.org/10.1038/nri.2017.49
Nater, U. M., Youngblood, L. S., Jones, J. F., Unger, E. R., Miller, A. H., Reeves, W. C., & Heim, C. (2008). Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosomatic Medicine, 70(3), 298–305.
National Comprehensive Cancer Network (NCCN). (2023). Cancer related fatigue NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®). (Vol. Version 2.2023 – January 30, 2023).
Noakes, T. D. (2012). Fatigue is a brain-derived emotion that regulates the exercise behavior to ensure the protection of whole body homeostasis. Frontiers in Physiology, 3(82), 1–13.
Nunes, E. J., Randall, P. A., Estrada, A., Epling, B., Hart, E. E., Lee, C. A., Baqi, Y., Müller, C. E., Correa, M., & Salamone, J. D. (2014). Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: Studies with the concurrent fixed ratio 5/chow feeding choice task. Psychopharmacology, 231(4), 727–736. https://doi.org/10.1007/s00213-013-3285-4
Nusslock, R., & Miller, G. E. (2016). Early-life adversity and physical and emotional health across the lifespan: A neuroimmune network hypothesis. Biological Psychiatry, 80(1), 23–32. https://doi.org/10.1016/j.biopsych.2015.05.017
O’Higgins, C. M., Brady, B., O’Connor, B., Walsh, D., & Reilly, R. B. (2018). The pathophysiology of cancer-related fatigue: Current controversies. Supportive Care in Cancer, 26(10), 3353–3364. https://doi.org/10.1007/s00520-018-4318-7
Omdal, R. (2020). The biological basis of chronic fatigue: Neuroinflammation and innate immunity. Current Opinion in Neurology, 33(3), 391–396. https://doi.org/10.1097/wco.0000000000000817
Papadopoulos, A. S., & Cleare, A. J. (2011). Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nature Reviews. Endocrinology, 8(1), 22–32. https://doi.org/10.1038/nrendo.2011.153
Payne, J. K. (2006). The trajectory of biomarkers in symptom management for older adults with cancer. Seminars in Oncology Nursing, 22(1), 31–35.
Pertl, M. M., Hevey, D., Collier, S., Lambe, K., & O’Dwyer, A.-M. (2014). Predictors of fatigue in cancer patients before and after chemotherapy. Journal of Health Psychology, 19(6), 699–710. https://doi.org/10.1177/1359105313477675
Pompeu, F. A. M. S. (2022). Why Pheidippides could not believe in the ‘Central Governor Model’: Popper’s philosophy applied to choose between two exercise physiology theories. Sports Med Health Sci, 4(1), 1–7. https://doi.org/10.1016/j.smhs.2021.10.001
Pyter, L. M. (2016). The influence of cancer on endocrine, immune, and behavioral stress responses. Physiology and Behavior, 166, 4–13. https://doi.org/10.1016/j.physbeh.2015.09.031
Querido, N. R., Kenkhuis, M. F., van Roekel, E. H., Breukink, S. O., van Duijnhoven, F. J. B., Janssen-Heijnen, M. L. G., Keulen, E. T. P., Ueland, P. M., Vogelaar, F. J., Wesselink, E., Bours, M. J. L., & Weijenberg, M. P. (2022). Longitudinal associations between inflammatory markers and fatigue up to two years after colorectal cancer treatment. Cancer Epidemiology, Biomarkers and Prevention, 31(8), 1638–1649. https://doi.org/10.1158/1055-9965.Epi-22-0077
Radin, A. S., Bower, J. E., Irwin, M. R., Asher, A., Hurvitz, S. A., Cole, S. W., Crespi, C. M., & Ganz, P. A. (2022). Acute health-related quality of life outcomes and systemic inflammatory markers following contemporary breast cancer surgery. NPJ Breast Cancer, 8(1), 91. https://doi.org/10.1038/s41523-022-00456-4
Raglan, G. B., & Schulkin, J. (2014). Introduction to allostasis and allostatic load. In M. Kent, C. Davis, & J. W. Reich (Hrsg.), The resilience handbook: Approaches to stress and trauma (S. 44–52). Routledge/Taylor & Francis Group.
Reidunsdatter, R. J., Albrektsen, G., Hjermstad, M. J., Rannestad, T., Oldervoll, L. M., & Lundgren, S. (2013). One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients – Comparison to general population. Acta Oncologica, 52(2), 239–248.
Reinertsen, K. V., Grenaker Alnaes, G. I., Landmark-Hoyvik, H., Loge, J. H., Wist, E., Kristensen, V. N., Fossa, S. D., & Edvardsen, H. (2011). Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway. Brain, Behavior, and Immunity, 25(7), 1376–1383.
Roerink, M. E., van der Schaaf, M. E., Dinarello, C. A., Knoop, H., & van der Meer, J. W. M. (2017). Interleukin-1 as a mediator of fatigue in disease: A narrative review. Journal of Neuroinflammation, 14(1), 16. https://doi.org/10.1186/s12974-017-0796-7
Saligan, L. N., & Kim, H. S. (2012). A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain, Behavior, and Immunity.
Saligan, L. N., Olson, K., Filler, K., Larkin, D., Cramp, F., Yennurajalingam, S., Escalante, C. P., del Giglio, A., Kober, K. M., Kamath, J., Palesh, O., & Mustian, K. (2015). The biology of cancer-related fatigue: A review of the literature. Supportive Care in Cancer, 23(8), 2461–2478. https://doi.org/10.1007/s00520-015-2763-0
Santos, J. C., & Pyter, L. M. (2018). Neuroimmunology of behavioral comorbidities associated with cancer and cancer treatments. Frontiers in Immunology, 9, 1195. https://doi.org/10.3389/fimmu.2018.01195
Schlauch, K. A., Khaiboullina, S. F., De Meirleir, K. L., Rawat, S., Petereit, J., Rizvanov, A. A., Blatt, N., Mijatovic, T., Kulick, D., Palotás, A., & Lombardi, V. C. (2016). Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome. Transl Psychiatry, 6(2), e730. https://doi.org/10.1038/tp.2015.208
Schmidt, M. E., Semik, J., Habermann, N., Wiskemann, J., Ulrich, C. M., & Steindorf, K. (2016). Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients. Brain, Behavior, and Immunity, 52, 98–105.
Scott, K., Phan, T. T., West, A. P., Taniguchi, C. M., & Dantzer, R. (2022). Neutralizing interleukin-6 in tumor-bearing mice does not abrogate behavioral fatigue induced by Lewis lung carcinoma. Behavioural Brain Research, 417, 113607. https://doi.org/10.1016/j.bbr.2021.113607
Sephton, S., & Spiegel, D. (2003). Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain, Behavior, and Immunity, 17(5), 321–328. https://doi.org/10.1016/S0889-1591(03)00078-3
Sloan, J. A., de Andrade, M., Decker, P., Wampfler, J., Oswold, C., Clark, M., & Yang, P. (2012). Genetic variations and patient-reported quality of life among patients with lung cancer. Journal of Clinical Oncology, 30(14), 1699–1704. https://doi.org/10.1200/jco.2010.34.5629
Solomon, A. M., Doorenbos, A., Li, H., Jang, M., Park, C., & Bronas, U. (2020). Allostatic load in cancer: A systematic review and mini meta-analysis. Biological Research for Nursing, 23. https://doi.org/10.1177/1099800420969898
Song, S., & Jason, L. A. (2009). A population-based study of chronic fatigue syndrome (CFS) experienced in differing patient groups: An effort to replicate Vercoulen et al.’s model of CFS. Journal of Mental Health, 14(3), 277–289. https://doi.org/10.1080/09638230500076165
St Clair Gibson, A., Swart, J., & Tucker, R. (2018). The interaction of psychological and physiological homeostatic drives and role of general control principles in the regulation of physiological systems, exercise and the fatigue process – The Integrative Governor theory. Eur J Sport Sci, 18(1), 25–36. https://doi.org/10.1080/17461391.2017.1321688
Stephan, K. E., Manjaly, Z. M., Mathys, C. D., Weber, L. A., Paliwal, S., Gard, T., Tittgemeyer, M., Fleming, S. M., Haker, H., Seth, A. K., & Petzschner, F. H. (2016). Allostatic self-efficacy: A metacognitive theory of dyshomeostasis-induced fatigue and depression. Frontiers in Human Neuroscience, 10, 550. https://doi.org/10.3389/fnhum.2016.00550
Sterling, P., & Eyer, J. (1988). Allostasis: A new paradigm to explain arousal pathology. In Handbook of life stress, cognition and health (S. 629–649). John Wiley & Sons.
Straub, R. H. (2017). The brain and immune system prompt energy shortage in chronic inflammation and ageing. Nature Reviews. Rheumatology, 13(12), 743–751. https://doi.org/10.1038/nrrheum.2017.172
Sunnquist, M., & Jason, L. A. (2018). A reexamination of the cognitive behavioral model of chronic fatigue syndrome. Journal of Clinical Psychology, 74(7), 1234–1245. https://doi.org/10.1002/jclp.22593
Sura, W., Murphy, S. O., & Gonzales, I. (2006). Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: A pilot study. Oncology Nursing Forum, 33(5), 1015–1021. https://doi.org/10.1188/06.ONF.1015-1021
Thayer, J. F., & Sternberg, E. (2006). Beyond heart rate variability: Vagal regulation of allostatic systems. Annals of the New York Academy of Sciences, 1088, 361–372. https://doi.org/10.1196/annals.1366.014
Theresa, T. D., Conway, K. A., Bender, C., Conley, Y. (2023). Genetic variability of oxidative stress and DNA repair genes associated with pre-treatment cancer-related fatigue in women with breast cancer. Supportive Care in Cancer, 31(6). https://doi.org/10.1007/s00520-023-07816-1
Toh, Y. L., Wong, E., Chae, J. W., Yap, N. Y., Yeo, A. H. L., Shwe, M., & Chan, A. (2020). Association of mitochondrial DNA content and displacement loop region sequence variations with cancer-related fatigue in breast cancer survivors receiving chemotherapy. Mitochondrion, 54, 65–71. https://doi.org/10.1016/j.mito.2020.07.004
Tornero-Aguilera, J. F., Jimenez-Morcillo, J., Rubio-Zarapuz, A., & Clemente-Suárez, V. J. (2022). Central and peripheral fatigue in physical exercise explained: A narrative review. International Journal of Environmental Research and Public Health, 19(7). https://doi.org/10.3390/ijerph19073909
Torossian, M., & Jacelon, C. S. (2021). Chronic illness and fatigue in older individuals: A systematic review. Rehabilitation Nursing, 46(3), 125–136. https://doi.org/10.1097/rnj.0000000000000278
Venhorst, A., Micklewright, D., & Noakes, T. D. (2018). Towards a three-dimensional framework of centrally regulated and goal-directed exercise behaviour: A narrative review. British Journal of Sports Medicine, 52(15), 957–966. https://doi.org/10.1136/bjsports-2016-096907
Vercoulen, J. H., Swanink, C. M., Galama, J. M., Fennis, J. F., Jongen, P. J., Hommes, O. R., van der Meer, J. W., & Bleijenberg, G. (1998). The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: Development of a model. Journal of Psychosomatic Research, 45(6), 507–517. https://doi.org/10.1016/s0022-3999(98)00023-3
Vichaya, E. G., Chiu, G. S., Krukowski, K., Lacourt, T. E., Kavelaars, A., Dantzer, R., Heijnen, C. J., & Walker, A. K. (2015). Mechanisms of chemotherapy-induced behavioral toxicities. Frontiers in Neuroscience, 9, 131.
Vichaya, E. G., Vermeer, D. W., Christian, D. L., Molkentine, J. M., Mason, K. A., Lee, J. H., & Dantzer, R. (2017). Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer. Psychoneuroendocrinology, 79, 59–66. https://doi.org/10.1016/j.psyneuen.2017.02.006
Vichaya, E. G., Grossberg, A. J., Molkentine, J., Estrada, D. J., Gross, P. S., Darpolor, J. K., Raj, P., Vermeer, D. W., Vermeer, P., Taniguchi, C., & Dantzer, R. (2019). Abstract # 3157 Elucidating the mechanisms of post-treatment cancer-related fatigue using a preclinical model. Brain, Behavior, and Immunity, 76, e32. https://doi.org/10.1016/j.bbi.2018.11.274
Vichaya, E. G., Ford, B. G., Quave, C. B., Rishi, M. R., Grossberg, A. J., & Dantzer, R. (2020). Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia. Psychoneuroendocrinology, 122, 104874. https://doi.org/10.1016/j.psyneuen.2020.104874
Vieira, E., Mirizio, G. G., Barin, G. R., de Andrade, R. V., Nimer, N. F. S., & La Sala, L. (2020). Clock genes, inflammation and the immune system – Implications for diabetes, obesity and neurodegenerative diseases. International Journal of Molecular Sciences, 21(24), E9743. https://doi.org/10.3390/ijms21249743
Wang, T., Yin, J., Miller, A. H., & Xiao, C. (2017). A systematic review of the association between fatigue and genetic polymorphisms. Brain, Behavior, and Immunity, 62, 230–244. https://doi.org/10.1016/j.bbi.2017.01.007
Wang, X. S., Shi, Q., Williams, L. A., Shah, N. D., Mendoza, T. R., Cohen, E. N., Reuben, J. M., Cleeland, C. S., & Orlowski, R. Z. (2015). Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leukemia and Lymphoma, 56(5), 1335–1341.
Weinrib, A. Z., Sephton, S. E., Degeest, K., Penedo, F., Bender, D., Zimmerman, B., Kirschbaum, C., Sood, A. K., Lubaroff, D. M., & Lutgendorf, S. K. (2010). Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer, 116(18), 4410–4419.
Weis, J., & Horneber, M. (2015). Cancer-related fatigue. Springer Healthcare. 2015th edition (27 Nov. 2014). ISBN-13: 9781907673757.
Wielgus, K. K., Berger, A. M., & Hertzog, M. (2009). Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncology Nursing Forum, 36(1), 38–48. https://doi.org/10.1188/09.ONF.38-48
Woo, B., Dibble, S. L., Piper, B. F., Keating, S. B., & Weiss, M. C. (1998). Differences in fatigue by treatment methods in women with breast cancer. Oncology Nursing Forum, 25(5), 915–920.
Wood, L. J., Nail, L. M., Perrin, N. A., Elsea, C. R., Fischer, A., & Druker, B. J. (2006). The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior–like symptoms in a mouse model of cancer chemotherapy–related symptoms. Biological Research for Nursing, 8(2), 157–169. https://doi.org/10.1177/1099800406290932
Xian, X., Zhu, C., Chen, Y., Huang, B., & Xu, D. (2021). A longitudinal analysis of fatigue in colorectal cancer patients during chemotherapy. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 29(9), 5245–5252. https://doi.org/10.1007/s00520-021-06097-w
Yang, G. S., Kumar, S., Dorsey, S. G., Starkweather, A. R., Kelly, D. L., & Lyon, D. E. (2019a). Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors. Supportive Care in Cancer, 27(2), 351–371. https://doi.org/10.1007/s00520-018-4508-3
Yang, S., Chu, S., Gao, Y., Ai, Q., Liu, Y., Li, X., & Chen, N. (2019b). A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis. Cells, 8(7). https://doi.org/10.3390/cells8070738
Yohn, S. E., Arif, Y., Haley, A., Tripodi, G., Baqi, Y., Müller, C. E., Miguel, N. S., Correa, M., & Salamone, J. D. (2016). Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: Pharmacological and neurochemical characterization. Psychopharmacology, 233(19–20), 3575–3586. https://doi.org/10.1007/s00213-016-4392-9
You, J., Dong, R., Ying, M., He, Q., Cao, J., & Yang, B. (2019). cellular senescence and anti-cancer therapy. Current Drug Targets, 20(7), 705–715. https://doi.org/10.2174/1389450120666181217100833
Zhang, C., Liang, Z., Ma, S., & Liu, X. (2021). Radiotherapy and cytokine storm: Risk and mechanism [Review]. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.670464
Zick, S. M., Sen, A., Wyatt, G. K., Murphy, S. L., Arnedt, J. T., & Harris, R. E. (2016). Investigation of 2 types of self-administered acupressure for persistent cancer-related fatigue in breast cancer survivors: A randomized clinical trial. JAMA Oncology, 2(11), 1470. https://doi.org/10.1001/jamaoncol.2016.1867
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Horneber, M., Weis, J. (2023). Ätiologie und Pathogenese. In: Tumorassoziierte Fatigue. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64615-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-64615-1_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-64614-4
Online ISBN: 978-3-662-64615-1
eBook Packages: Medicine (German Language)